Eliphos
- Product NDC
- 68151-5204
- 11-digit product format
- 681515204
- Labeler code
- 68151
- Product ID
- 68151-5204_4293136c-1c66-4e16-b40e-0ddb42c59211
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Calcium Acetate
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Carilion Materials Management
- Application
- ANDA078502
- Marketing category
- ANDA
- Marketing start
- 2009-02-01
- Marketing end
- 0000-00-00
- Substance
- CALCIUM ACETATE
- Active strength
- 667 mg/1
- Pharmacologic classes
- Blood Coagulation Factor [EPC],Increased Coagulation Factor Activity [PE],Calcium [CS],Cations, Divalent [CS]
- NDC exclude flag
- E
- Listing certified through
- 2018-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| bee4fa8d-8d82-423a-a0b5-40a89dd13a99 | Product name | 1 | 20250618 |
| e0d2eb29-08bd-4bba-90d1-c91c68a38767 | Product name | 4 | 20250516 |
| 30b0ac6e-02aa-0e5c-0d8b-cffdf3a282b2 | Product name | 5 | 20250304 |
| 334fe8d2-68fb-4331-a576-420e302ec069 | Product name | 7 | 20240320 |
| 444b3e50-f226-46ef-bfca-2e7035d140cd | Product name | 1 | 20190611 |
| e92765c1-be81-432a-b909-1b10777ec378 | Product name | 1 | 20190208 |
| 7cda52fc-125f-421c-8fea-bc1974370c49 | Product name | 2 | 20180703 |
| d5e51f11-ad28-caa4-4b49-4143974782ad | Product name | 1 | 20150831 |
| 0ca1d589-929b-4b33-bc5b-1d84abdafa6a | Product name | 1 | 20150324 |
| fc363c46-397b-4476-ac0f-70e43e8e4592 | Product name | 1 | 20150324 |
| 0441a8f5-3835-497c-aedd-bc78cba56b2a | Product name | 1 | 20150317 |
| 87711080-88eb-65c5-b2dd-bf99e700a372 | Product name | 1 | 20140508 |
| ec2149b3-5c6d-5344-f757-c86411073075 | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 68151-5204-0 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-a516-f424-e053-dadaa90a57ce | These highlights do not include all the information needed to use ELIPHOS ® Tablets safely and effectively. See full prescribing information for ELIPHOS ® Tablets. ELIPHOS ® Tablets (calcium acetate): 667 mg Initial U.S. Approval: 1990 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68151-5204-0 | Eliphos | 1 in 1 PACKAGE | TABLET | 1 | 3 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Calcium Acetate | ACTIVE INGREDIENT | Y882YXF34X | ELIPHOS (CALCIUM ACETATE) TABLET [CARILION MATERIALS MANAGEMENT] | 2 | |
| Calcium Cation | ACTIVE MOIETY | 2M83C4R6ZB | ELIPHOS (CALCIUM ACETATE) TABLET [CARILION MATERIALS MANAGEMENT] | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68151-5204 | ELIPHOS (CALCIUM ACETATE) TABLET [CARILION MATERIALS MANAGEMENT] | 3 | Legacy NDC, 1 package rows | 20160806_9fc1ada4-9ef4-48e9-8203-32aa857d0429.zip |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 197433 | calcium 169 MG Oral Tablet, as calcium acetate | PSN | 9fc1ada4-9ef4-48e9-8203-32aa857d0429 | 3 |
| 830642 | ELIPHOS Tablets 667 MG (Ca 169 MG) Oral Tablet | PSN | 9fc1ada4-9ef4-48e9-8203-32aa857d0429 | 3 |
| 830642 | calcium acetate 667 MG Oral Tablet [Eliphos] | SBD | 9fc1ada4-9ef4-48e9-8203-32aa857d0429 | 3 |
| 197433 | calcium acetate 667 MG Oral Tablet | SCD | 9fc1ada4-9ef4-48e9-8203-32aa857d0429 | 3 |
| 197433 | calcium acetate 667 MG (calcium 169 MG) Oral Tablet | SY | 9fc1ada4-9ef4-48e9-8203-32aa857d0429 | 3 |
| 830642 | Eliphos Calcium Acetate 667 (Calcium 169 MG) Oral Tablet | SY | 9fc1ada4-9ef4-48e9-8203-32aa857d0429 | 3 |
Packages#
| Package NDC | 11-digit format | Description | Status |
|---|---|---|---|
| 68151-5204-0 | 68151520400 | 1 in 1 PACKAGE | Historical |